Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule

The licensed VHH antibody molecule originates from RenNano, Biocytogen’s technology designed to identify fully human VHH antibodies. Credit: Anamaria Mejia / Shutterstock.com.